Global Ophthalmic Knives Market
Ophthalmic Knives Market Projected to Surge to USD 3.21 Billion by 2030, Exhibiting a CAGR of 5.69% During 2024-2030
January 23, 2024 00:38 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Knives Market by Product Type (Crescent Knives, MVR Knives, Slit Knives), Usage (Disposable, Reusable), Blade Type, Application, End...
Global Ophthalmic Viscosurgical Devices Market
Global Ophthalmic Viscosurgical Devices Market to Reach USD 1,171.29 Million by 2030: Unveiling a Comprehensive Research Report
January 23, 2024 00:33 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Viscosurgical Devices Market by Product (Cohesive, Combined, Dispersive), Application (Cataract Surgery, Glaucoma Surgery,...
Global Minimally Invasive Glaucoma Surgery Devices Market
Minimally Invasive Glaucoma Surgery Devices Market Forecasts Promising Growth by 2030: In-depth Analysis Spanning Suprachoroidal Space and Stand-Alone Procedures
January 18, 2024 22:18 ET | Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Global Minimally Invasive Glaucoma Surgery Devices Market by Target (Suprachoroidal Space, Trabecular Meshwork), Surgery (Glaucoma in Conjunction with...
Global Optical Coherence Tomography for Ophthalmology Market
Optical Coherence Tomography in Ophthalmology Market Forecast: Significant Growth Predicted with Rising CAGR of 17.12% by 2030
January 09, 2024 16:33 ET | Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Optical Coherence Tomography for Ophthalmology Market by Product (Catheter-based OCT Devices, Doppler OCT Devices, Handheld OCT Devices), Type...
Global Glaucoma Surgery Devices Market
Glaucoma Surgery Devices Market Forecasted for Robust Growth, Focusing on Innovations in Laser and Minimally Invasive Procedures
January 09, 2024 16:18 ET | Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Glaucoma Surgery Devices Market by Product (Algerbrush, Diamond Knives, Forceps), Surgery Method (Laser Surgery, Minimal Invasive Glaucoma...
Margot Goodkin -  Headshot
SpyGlass Pharma Strengthens Leadership to Further Advance its Intraocular Drug Delivery Platform
December 05, 2023 09:00 ET | SpyGlass Pharma, Inc.
Margot Goodkin, M.D., Ph.D., appointed Chief Medical OfficerBilal Khan, MBA, CEO of New World Medical, appointed to the SpyGlass Board of Directors ALISO VIEJO, Calif., Dec. 05, 2023 (GLOBE...
Global Ophthalmology PACS Market
Ophthalmology PACS (Integrated, Standalone) Market Analysis Report 2023: A Global $248 Million Market by 2030 - Increased Prevalence of Various Eye Diseases Fueling Demand
November 14, 2023 03:28 ET | Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Ophthalmology PACS Market Size, Share & Trends Analysis Report By Type (Integrated, Standalone), By Mode Of Action (Cloud-based, On-premise), By...
Logo.png
Glaucoma Market to Accelerate Substantially During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies - Nicox, SPARC, Visiox, Glaukos, Ono, Santen, Ocular, Tarsier, Peregrine Ophthalmic, Ocuphire
November 08, 2023 13:00 ET | DelveInsight Business Research LLP
New York, USA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Glaucoma Market to Accelerate Substantially During the Forecast Period (2023–2032), Examines DelveInsight | Leading Companies - Nicox, SPARC, Visiox,...
Global Glaucoma Surgery Devices Market
Global Glaucoma Surgery Devices Market to Reach $2.27 Billion by 2030, Driven by Rising Burden of Glaucoma and Minimally Invasive Procedures
October 31, 2023 09:28 ET | Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Glaucoma Surgery Devices Market Size, Share & Trends Analysis Report By Product (Laser Systems, Diamond Knives), By Surgery Method (MIGS, Laser...
Spyglass Pharma Logo - Long.png
SpyGlass Pharma Initiates Phase I/II Clinical Trial of its Intraocular Drug Delivery Platform
October 31, 2023 07:00 ET | SpyGlass Pharma, Inc.
ALISO VIEJO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, announced today the initiation of a Phase I/II clinical trial...